Low dose Nivolumab Phase 3. #ASCO2022 . Vanita Noronha, MBBS MD DM Nandini Menon Amol Patel Dr Amol Akhade @SachinD78722095 Deep Vora Bharat TMH Medical Oncology Alumni ATOM Coalition

Wrapping #ASCO2022 with broche de oro

Absolutely unbelievable data by Andrea Cercek Memorial Sloan Kettering Cancer Center at ASCO #ASCO2022 : 100% CR rate in 14 consecutive high risk (90%+st3) rectal cancer pts w/ Dostarlimab PD1 monotherapy. NO PATIENT REQUIRED CHEMO/SURGERY/RT. #immunoablative therapy is here + published now in NEJM

Excited for Chris Hourigan to present our latest results tomorrow at 11:45AM CT from the Pre-MEASURE study at #ASCO2022 examining #MRD in a large cohort of #AML patients prior to transplant. Stick around for the last session! #savingthebest4last bit.ly/3t0LjBe

Institut Jules Bordet Instituut team at #ASCO2022

ASCO ESMO - Eur. Oncology Belgian Society of Medical Oncology

Our last day at #ASCO2022 with a matching color pallet! The Mother-Daughter Oncologist Duo strikes again! Couldn’t be more proud of you! ♥️
#LatinosInOncology
#womeninoncology
Clarissa Mathias
ASCO

Multiple Myelomada ömür uzuyor!
1990-2000: 2-3 yıl
2000-2010: 4-7 yıl
2010-2019: 8-10 yıl
2020 ve sonrası: 10 yıldan fazla
CART hücreleri çığır mı açıyor?

#ASCO2022
#myeloma
#multiplemyeloma
#CARThucre
#CARTcelltherapy
#profdrfevzialtuntas

Today I had the pleasure of presenting a part of our project on the impact of immunotherapy in elderly patients with NSCLC. Thank you, Mark Awad, for the inspiration and support, and my colleagues for collaboration. #ASCO2022 #GeriOnc #LCSM

Happening now at S504 Enrique Soto , Martine extermann SIOG SIOGNAH Young SIOG OncoAlert Najia Musolino #ASCO2022

Privileged to present #ASCO2022 : Time at Home among older AML patients. meetings.asco.org/abstracts-pres…
Method: A propensity weighted SEER-Medicare dataset
Results:
1. Treatment burdens very high
2. Pts tx w/Intensive Induction lived longer, but had less time at home v. HMA-tx pts

Congratulations to PGY1 WashU Internal Medicine Residency Program koral shah, md on her poster at #ASCO2022 🎉🎉🎉

#WomenInMedicine #MedTwitter #MedEd ASCO

Tüm Katılımcı ve Konuşmacı Hocalarımıza Teşekkür Ederiz. #WebTARGED
#KongredenBildiriYORUM #ASCO 2022 #ASCO 22 #ASCO

Amazing recap of #ASCO2022 #sarcoma highlights by Gina Z. D'Amato, MD. Sylvester Comprehensive Cancer Center, so proud to work with such an awesome team Jon Trent, MD, PhD Andrea Espejo-Freire MD Priscila Barreto Coelho, MD Aditi Dhir UMiami Health System

🚨Our review of major #Lung #Cancer Treatment Advances in #ASCO2022 is out now in #Cancer Investigation #LCSM dream team 🌟Aakash Desai, MD, MPH Eric K. Singhi, MD @drRTee Muhammad Salman Faisal

#LCSM ASCO OncoAlert ESMO - Eur. Oncology IASLC Henry Ford Hematology/Oncology Fellowship

🔗 doi.org/10.1080/073579…

A quick break from #ASCO2022 to run Chicago Half Marathon #ChiThirteenOne . Finished in 1:46:57, 16th in my category (the ancient but still moving). Now back to #ASCO2022 .

Honored to meet Nobel Prize winner Dr Allison and his wife Dr Sharma at the MD Anderson Cancer Center #ASCO2022 reception with good friend Jing Li

ENZAMET updates #ASCO2022 always thoughtful Ian Davis ! Well Done ANZUP Australia ! Combo Doce/Enzo +break the ‘curse’ of de novo high volume PCa? silke gillessen OncoAlert Neeraj Agarwal, MD, FASCO Axel S. Merseburger Boris Hadaschik Christopher Sweeney, MBBS

Amazing to catch up with my friend @NarjustDumaMD at ASCO. ❤️ #gratitude #ASCO2022 #Florezlab Coral Olazagasti, MD Ana I. Velázquez Mañana, MD MSc (she/her/ella)

Enjoyed meeting and discussing opportunities #cancer #drugdevelopment with the inspiring Vivek Subbiah, MD MD Anderson Cancer Center #asco22 #ASCO2022

My 2nd baby went to his first ASCO meeting! #asco2022 😊🐣 Photo at ASCO by mariahkarson.com